EVH - Evolent Health, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
614.45M
Enterprise Value 3
804.47M
Trailing P/E
N/A
Forward P/E 1
-121.17
PEG Ratio (5 yr expected) 1
-0.35
Price/Sales (ttm)
0.84
Price/Book (mrq)
0.54
Enterprise Value/Revenue 3
1.10
Enterprise Value/EBITDA 6
-16.81

Trading Information

Stock Price History

Beta (3Y Monthly) 0.98
52-Week Change 3-72.08%
S&P500 52-Week Change 38.19%
52 Week High 326.96
52 Week Low 35.50
50-Day Moving Average 37.36
200-Day Moving Average 39.30

Share Statistics

Avg Vol (3 month) 31.3M
Avg Vol (10 day) 3791.14k
Shares Outstanding 583.81M
Float 73.65M
% Held by Insiders 112.68%
% Held by Institutions 1106.95%
Shares Short (Sep 30, 2019) 414.94M
Short Ratio (Sep 30, 2019) 411.31
Short % of Float (Sep 30, 2019) 420.01%
Short % of Shares Outstanding (Sep 30, 2019) 417.68%
Shares Short (prior month Aug 30, 2019) 413.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -14.67%
Operating Margin (ttm)-11.85%

Management Effectiveness

Return on Assets (ttm)-3.65%
Return on Equity (ttm)-10.07%

Income Statement

Revenue (ttm)732.77M
Revenue Per Share (ttm)9.21
Quarterly Revenue Growth (yoy)33.00%
Gross Profit (ttm)228.35M
EBITDA -47.87M
Net Income Avi to Common (ttm)-107.47M
Diluted EPS (ttm)-1.35
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)96.87M
Total Cash Per Share (mrq)1.16
Total Debt (mrq)301.09M
Total Debt/Equity (mrq)26.26
Current Ratio (mrq)1.39
Book Value Per Share (mrq)13.49

Cash Flow Statement

Operating Cash Flow (ttm)-41.89M
Levered Free Cash Flow (ttm)24.37M